Beta 2-adrenoceptor antagonists intensify clonidine withdrawal syndrome in conscious rats.

Journal of Cardiovascular Pharmacology
F A JonkmanP A van Zwieten

Abstract

Sudden cessation of prolonged treatment with clonidine in conscious rats evokes a cardiovascular withdrawal syndrome, characterized by severe tachycardia and brief blood pressure (BP) increases, so-called "upswings." Previously, adenylate cyclase-coupled alpha 2-adrenoceptors were shown to be involved in this phenomenon. In the present study, the effect on the intensity of clonidine withdrawal symptoms of concomitant treatment with various beta-adrenoceptor antagonists during clonidine infusion (100 micrograms/kg/24 h, 7 days) was investigated. Propranolol (18 mg/kg/24 h, beta 1 and beta 2 blocker) and ICI 118.551 (12 mg/kg/24 h, beta 2 blocker) clearly aggravated the withdrawal symptoms, whereas metoprolol (18 mg/kg/24 h, beta 1 blocker) did not affect the severity of the withdrawal syndrome. Accordingly, intensification of the withdrawal syndrome appears to be mediated by beta 2- rather than by beta 1-adrenoceptors. These results point to an interaction at the level of the second-messenger adenylate cyclase (AC) system in development of clonidine withdrawal syndrome.

Citations

Jun 20, 2002·Pharmacology & Toxicology·Ahmad Reza DehpourAbbas Nowroozy Javidan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.